H2AL3
gene geneOn this page
Also known as H2A.L.3
Summary
H2AL3 (H2A.L variant histone 3, HGNC:53960) is a protein-coding gene on chromosome Xp11.4, encoding Histone H2A-like 3 (A0A3B3IU63). Core component of nucleosome.
Predicted to be a structural constituent of chromatin. Predicted to be involved in heterochromatin formation. Predicted to be located in chromosome. Predicted to be part of nucleosome. Predicted to be active in nucleus.
Source: NCBI Gene 115482686 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001395555
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53960 |
| Approved symbol | H2AL3 |
| Name | H2A.L variant histone 3 |
| Location | Xp11.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | H2A.L.3 |
| Ensembl gene | ENSG00000229674 |
| Ensembl biotype | protein_coding |
| Entrez | 115482686 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000448797
RefSeq mRNA: 1 — MANE Select: NM_001395555
NM_001395555
CCDS: CCDS94587
Canonical transcript exons
ENST00000448797 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003978222 | 37994272 | 37994904 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 63.48.
Top tissues by expression
104 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 63.48 | gold quality |
| left testis | UBERON:0004533 | 62.61 | gold quality |
| testis | UBERON:0000473 | 62.59 | gold quality |
| sural nerve | UBERON:0015488 | 54.79 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 47.98 | gold quality |
| granulocyte | CL:0000094 | 39.70 | gold quality |
| hypothalamus | UBERON:0001898 | 38.39 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 33.21 | gold quality |
| gall bladder | UBERON:0002110 | 33.08 | gold quality |
| islet of Langerhans | UBERON:0000006 | 33.02 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| adenohypophysis | UBERON:0002196 | 31.64 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| putamen | UBERON:0001874 | 30.27 | gold quality |
| nucleus accumbens | UBERON:0001882 | 30.11 | silver quality |
| pituitary gland | UBERON:0000007 | 30.08 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 29.32 | silver quality |
| endometrium | UBERON:0001295 | 28.99 | gold quality |
| pancreas | UBERON:0001264 | 28.49 | gold quality |
| transverse colon | UBERON:0001157 | 28.32 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.29 |
Regulation
Is transcription factor: no
Cross-species orthologs
38 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | H2al1o | ENSMUSG00000061065 |
| mus_musculus | H2al2a | ENSMUSG00000062651 |
| mus_musculus | H2al1j | ENSMUSG00000069038 |
| mus_musculus | H2al1n | ENSMUSG00000078346 |
| mus_musculus | H2al2c | ENSMUSG00000094881 |
| mus_musculus | H2al1d | ENSMUSG00000094904 |
| mus_musculus | H2al1e | ENSMUSG00000095413 |
| mus_musculus | H2al1i | ENSMUSG00000095445 |
| mus_musculus | H2al2b | ENSMUSG00000095573 |
| mus_musculus | H2al1f | ENSMUSG00000095655 |
| mus_musculus | H2al1g | ENSMUSG00000095662 |
| mus_musculus | H2al1c | ENSMUSG00000096097 |
| mus_musculus | H2al1h | ENSMUSG00000099443 |
| mus_musculus | H2al1m | ENSMUSG00000100200 |
| mus_musculus | H2al1k | ENSMUSG00000100448 |
| mus_musculus | H2al1a | ENSMUSG00000100626 |
| mus_musculus | H2al1b | ENSMUSG00000101819 |
| rattus_norvegicus | H2al3 | ENSRNOG00000079918 |
| drosophila_melanogaster | His2A:CG31618 | FBGN0051618 |
| drosophila_melanogaster | His2A:CG33808 | FBGN0053808 |
| drosophila_melanogaster | His2A:CG33814 | FBGN0053814 |
| drosophila_melanogaster | His2A:CG33817 | FBGN0053817 |
| drosophila_melanogaster | His2A:CG33820 | FBGN0053820 |
| drosophila_melanogaster | His2A:CG33823 | FBGN0053823 |
| drosophila_melanogaster | His2A:CG33826 | FBGN0053826 |
| drosophila_melanogaster | His2A:CG33829 | FBGN0053829 |
| drosophila_melanogaster | His2A:CG33832 | FBGN0053832 |
| drosophila_melanogaster | His2A:CG33835 | FBGN0053835 |
| drosophila_melanogaster | His2A:CG33838 | FBGN0053838 |
| drosophila_melanogaster | His2A:CG33841 | FBGN0053841 |
| drosophila_melanogaster | His2A:CG33844 | FBGN0053844 |
| drosophila_melanogaster | His2A:CG33847 | FBGN0053847 |
| drosophila_melanogaster | His2A:CG33850 | FBGN0053850 |
| drosophila_melanogaster | His2A:CG33853 | FBGN0053853 |
| drosophila_melanogaster | His2A:CG33856 | FBGN0053856 |
| drosophila_melanogaster | His2A:CG33859 | FBGN0053859 |
| drosophila_melanogaster | His2A:CG33862 | FBGN0053862 |
| drosophila_melanogaster | His2A:CG33865 | FBGN0053865 |
Paralogs (27): MACROH2A2 (ENSG00000099284), H2AZ2 (ENSG00000105968), MACROH2A1 (ENSG00000113648), H2AZ1 (ENSG00000164032), H2AC1 (ENSG00000164508), H2AC6 (ENSG00000180573), H2AC25 (ENSG00000181218), H2AC20 (ENSG00000184260), H2AC21 (ENSG00000184270), H2AX (ENSG00000188486), H2AC13 (ENSG00000196747), H2AC11 (ENSG00000196787), H2AC7 (ENSG00000196866), H2AJ (ENSG00000246705), H2AL1Q (ENSG00000249467), H2AB1 (ENSG00000274183), H2AC12 (ENSG00000274997), H2AC15 (ENSG00000275221), H2AC14 (ENSG00000276368), H2AC16 (ENSG00000276903), H2AC8 (ENSG00000277075), H2AB3 (ENSG00000277745), H2AB2 (ENSG00000277858), H2AC4 (ENSG00000278463), H2AC17 (ENSG00000278677), H2AC18 (ENSG00000288825), H2AC19 (ENSG00000288859)
Protein
Protein identifiers
Histone H2A-like 3 — A0A3B3IU63 (reviewed: A0A3B3IU63)
All UniProt accessions (1): A0A3B3IU63
UniProt curated annotations — full annotation on UniProt →
Function. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.
Subcellular location. Nucleus. Chromosome.
Similarity. Belongs to the histone H2A family.
RefSeq proteins (1): NP_001382484* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002119 | Histone_H2A | Family |
| IPR009072 | Histone-fold | Homologous_superfamily |
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A3B3IU63-F1 | 77.18 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOCC_PROTEIN_DNA_COMPLEX, GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, chrXp11, BILANGES_SERUM_SENSITIVE_VIA_TSC2, RB_P130_DN.V1_UP, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION, GOCC_NUCLEOSOME, GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN
GO Biological Process (1): heterochromatin formation (GO:0031507)
GO Molecular Function (3): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982)
GO Cellular Component (3): nucleosome (GO:0000786), nucleus (GO:0005634), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin | 2 |
| cellular component assembly | 1 |
| heterochromatin boundary formation | 1 |
| negative regulation of gene expression, epigenetic | 1 |
| heterochromatin organization | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| protein dimerization activity | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
706 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H2AL3 | CENPT | Q96BT3 | 375 |
| H2AL3 | TRAM1L1 | Q8N609 | 370 |
| H2AL3 | BHLHA9 | Q7RTU4 | 327 |
| H2AL3 | ASCL5 | Q7RTU5 | 311 |
| H2AL3 | FERD3L | Q96RJ6 | 277 |
| H2AL3 | ARL11 | Q969Q4 | 271 |
| H2AL3 | PCDH11X | Q9BZA7 | 269 |
| H2AL3 | PCDHB4 | Q9Y5E5 | 262 |
| H2AL3 | PCDHB10 | Q9UN67 | 262 |
| H2AL3 | NPBWR2 | P48146 | 253 |
| H2AL3 | PCDHB7 | Q9Y5E2 | 248 |
| H2AL3 | CDK5R2 | Q13319 | 247 |
| H2AL3 | H1-0 | P07305 | 245 |
| H2AL3 | PCDHB3 | Q9Y5E6 | 242 |
| H2AL3 | BHLHE23 | Q8NDY6 | 242 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1W2PP81, A0A1W2PPE2, A0A1W2PPH5, A0A1W2PPL8, A0A1W2PR64, A0A1W2PRV1, A0A3B3IU63, A4QVR2, A5DQL2, A9UMV8, F4HR03, O35216, P06898, P0C1H6, P0C5Y9, P0C5Z0, P0DW11, P0DW12, P0DW13, P0DW14, P0DW85, P35061, P48003, P49450, Q00728, Q3SZB8, Q3ZBX9, Q4IMD1, Q5M8Q2, Q5TKR9, Q64522, Q64598, Q7Z2G1, Q803H4, Q873G4, Q8BRB7, Q8BZ21, Q8CGP5, Q8IUE6, Q8R1M2
Diamond homologs: A0A3B3IU63, A1A4R1, A2WQG7, A5DBG4, A5DJJ2, A5DXS8, A9UMV8, C0HKE1, C0HKE2, C0HKE3, C0HKE4, C0HKE5, C0HKE6, C0HKE7, C0HKE8, C0HKE9, P02262, P02263, P02264, P02269, P02270, P02273, P02274, P02276, P02277, P04908, P06897, P07793, P09588, P0C0S8, P0C0S9, P0C169, P0C170, P0C5Y9, P0C5Z0, P0CC09, P0CN98, P0CN99, P13630, P13912
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
25 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:37994499:T:A | acceptor_gain | 0.6600 |
| X:37994713:G:GT | donor_gain | 0.5400 |
| X:37994689:G:GT | donor_gain | 0.5300 |
| X:37994374:AGGAG:A | acceptor_gain | 0.5200 |
| X:37994716:G:GT | donor_gain | 0.4600 |
| X:37994865:T:TA | donor_gain | 0.4400 |
| X:37994727:G:GA | donor_gain | 0.3900 |
| X:37994695:G:GT | donor_gain | 0.3400 |
| X:37994495:T:TA | acceptor_gain | 0.3300 |
| X:37994726:T:TA | donor_gain | 0.3300 |
| X:37994884:C:G | donor_gain | 0.3300 |
| X:37994900:A:G | donor_gain | 0.3200 |
| X:37994686:G:GT | donor_gain | 0.3000 |
| X:37994704:G:GT | donor_gain | 0.3000 |
| X:37994399:GAA:G | acceptor_gain | 0.2900 |
| X:37994373:TAGGA:T | acceptor_gain | 0.2700 |
| X:37994663:TAG:T | donor_gain | 0.2500 |
| X:37994664:AGA:A | donor_gain | 0.2500 |
| X:37994641:G:GT | donor_gain | 0.2300 |
| X:37994698:G:GT | donor_gain | 0.2300 |
| X:37994399:GAAGA:G | acceptor_gain | 0.2200 |
| X:37994701:G:GT | donor_gain | 0.2200 |
| X:37994894:GT:G | donor_gain | 0.2200 |
| X:37994611:GA:G | donor_gain | 0.2100 |
| X:37994367:TAGG:T | acceptor_gain | 0.2000 |
AlphaMissense
977 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:37994491:T:C | F50L | 0.938 |
| X:37994493:C:A | F50L | 0.938 |
| X:37994493:C:G | F50L | 0.938 |
| X:37994416:T:C | F25L | 0.907 |
| X:37994418:T:A | F25L | 0.907 |
| X:37994418:T:G | F25L | 0.907 |
| X:37994521:G:C | A60P | 0.792 |
| X:37994417:T:C | F25S | 0.782 |
| X:37994417:T:G | F25C | 0.777 |
| X:37994492:T:C | F50S | 0.746 |
| X:37994576:T:C | I78T | 0.730 |
| X:37994516:T:C | L58P | 0.727 |
| X:37994511:G:C | E56D | 0.692 |
| X:37994511:G:T | E56D | 0.692 |
| X:37994504:T:A | V54D | 0.685 |
| X:37994510:A:T | E56V | 0.685 |
| X:37994423:T:A | V27D | 0.665 |
| X:37994473:A:C | S44R | 0.657 |
| X:37994475:C:A | S44R | 0.657 |
| X:37994475:C:G | S44R | 0.657 |
| X:37994576:T:G | I78S | 0.645 |
| X:37994438:G:C | R32P | 0.642 |
| X:37994599:G:C | A86P | 0.637 |
| X:37994492:T:G | F50C | 0.633 |
| X:37994501:G:A | G53D | 0.626 |
| X:37994507:T:A | L55H | 0.626 |
| X:37994576:T:A | I78N | 0.626 |
| X:37994603:T:C | L87P | 0.623 |
| X:37994498:C:A | A52D | 0.613 |
| X:37994512:T:C | Y57H | 0.611 |
dbSNP variants (sampled 300 via entrez): RS1000949566 (X:37993535 A>G), RS1001001752 (X:37993160 C>T), RS1001346865 (X:37994043 C>A,T), RS1004127988 (X:37992300 G>A), RS1005539599 (X:37994465 G>A,C), RS1007855995 (X:37994213 G>A), RS1008308646 (X:37993380 C>A), RS1008323756 (X:37993685 G>A), RS1008914156 (X:37995251 G>A), RS1010767404 (X:37995216 A>G), RS1012037107 (X:37994568 G>A), RS10127316 (X:37993793 G>C,T), RS1013662480 (X:37993058 C>T), RS1013973393 (X:37992822 C>G,T), RS1015307269 (X:37993708 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.